eISSN 2508-3589
pISSN 2508-1926

Table. 1.

Table. 1.

Demographics and clinical characteristics

Parameter Total (n = 51) Larger extent smaller extent (n = 26) p-value
Age (years) 68.86 ± 5.79 67.60 ± 5.47 70.08 ± 5.93 0.221
Sex, male:female 21:30 11:14 10:16 0.231
BCVA (logMAR) 0.36 ± 0.15 0.40 ± 0.18 0.33 ± 0.12 0.092
M-score 0.58 ± 0.21 0.70 ± 0.15 0.48 ± 0.19 < 0.001
Spherical equivalent (diopter) 0.25 ± 1.30 0.45 ± 1.27 0.07 ± 1.29 0.248
SEPB 8 (15) 6 (24) 2 (8) 0.140§
ERM type, DIF:CME:PLH 20:21:10 10:8:7 10:13:3 0.256
Dye, ICG:TA 20:31 13:12 7:19 0.061
Cataract combine operation 29 (57) 15 (60) 14 (54) 0.779
Three months after surgery
BCVA (logMAR) 0.23 ± 0.13 0.27 ± 0.16 0.20 ± 0.07 0.077
BCVA changes* (logMAR) 0.13 ± 0.17 0.13 ± 0.20 0.13 ± 0.12 0.921
Inner retinal dimple number 10.33 ± 1.92 10.88 ± 1.70 9.81 ± 2.00 0.059
Inner retinal dimple extent (mm2) 0.73 ± 0.13 0.84 ± 0.06 0.63 ± 0.07 < 0.001

Values are presented as mean ± standard deviation or number (%) unless otherwise indicated.

BCVA = best corrected visual acuity; logMAR = logarithm of the minimum angle of resolution; M-score = metamorphopsia score; SEPB = secondary epiretinal membrane due to peripheral break; ERM = epiretinal membrane; DIF = diffuse type; CME = cystoid macular edema type; PLH = pseudolamellar hole; ICG = indocyanine green; TA = triamcinolone acetonide.

*BCVA changes mean the amount of change in BCVA at 3 months after surgery from BCVA before surgery; Mann-Whitney U test; Chi sqaure test; §Fisher’s exact test.

J Retin 2022;7:27-34 https://doi.org/10.21561/jor.2022.7.1.27
© 2022 J Retin